{"id":21128,"date":"2024-01-10T18:51:00","date_gmt":"2024-01-10T18:51:00","guid":{"rendered":"https:\/\/www.spaininvestorsday.com\/?p=21128"},"modified":"2024-01-10T18:51:00","modified_gmt":"2024-01-10T18:51:00","slug":"la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud","status":"publish","type":"post","link":"https:\/\/www.spaininvestorsday.com\/en\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/","title":{"rendered":"LA COLABORACION P\u00daBLICO-PRIVADA, CLAVE PARA EL DESARROLLO DEL SECTOR SALUD"},"content":{"rendered":"<ul>\n<li><strong>Rick R. Su\u00e1rez, presidente de Astrazeneca Espa\u00f1a, avanz\u00f3 que \u201centre 2024 y 2027 una inversi\u00f3n de 800 millones con el <em>hub<\/em> de innovaci\u00f3n Barcelona\u201d<\/strong><\/li>\n<\/ul>\n<p><strong>Madrid 10\/01\/2024-. <\/strong>En los \u00faltimos a\u00f1os, Espa\u00f1a ha experimentado un espectacular avance en materia de salud, y la biotecnolog\u00eda tiene un peso cada vez mayor en la econom\u00eda del pa\u00eds. Por ello, desde el foro econ\u00f3mico Spain Investors Day, en su edici\u00f3n XIV, el panel de expertos reunidos en torno a la mesa \u201cLa aportaci\u00f3n del sector biotecnol\u00f3gico a la investigaci\u00f3n e innovaci\u00f3n en Espa\u00f1a\u201d, coincidi\u00f3 en importancia de la colaboraci\u00f3n p\u00fablico-privada para que Espa\u00f1a siga siendo un pa\u00eds referente en el sector sanitario a escala mundial.<\/p>\n<p>El <strong>secretario de Estado de Sanidad, Javier Padilla<\/strong>, form\u00f3 parte del coloquio, y puso de relevancia que \u201cEspa\u00f1a es lugar para estar en el sector biotecnol\u00f3gico por el liderazgo en el \u00e1mbito de ensayos cl\u00ednicos de medicamentos\u201d. Durante su intervenci\u00f3n, hizo referencia a \u201cla necesidad de poder establecer mecanismos coordinados de colaboraci\u00f3n entre los diferentes agentes para dar respuestas a las necesidades de salud\u201d.<\/p>\n<p>Por su parte,<strong> Rick R. Su\u00e1rez, presidente de ASTRAZENECA Espa\u00f1a<\/strong>, destac\u00f3 que \u201cEspa\u00f1a es n\u00famero uno en Europea y n\u00famero dos a nivel mundial en cuanto a inversi\u00f3n en ensayos cl\u00ednicos, lo que implica inversiones de 1.200 millones de euros en ensayos cl\u00ednicos, el equivalente a un 20% de la inversi\u00f3n total en salud e investigaci\u00f3n sanitaria\u201d. En ese sentido, reconoci\u00f3 que el apoyo y confianza de ASTRAZENECA en nuestro pa\u00eds se evidencia con los 400 millones de euros invertidos en Espa\u00f1a en 2024, un incremento considerable desde la inversi\u00f3n de los 90 millones de euros en 2020. \u201cA partir de 2024, adem\u00e1s, planeamos hacer una inversi\u00f3n de 800 millones de euros, lo que supondr\u00e1 el 10% del total de inversiones en ensayos cl\u00ednicos en Espa\u00f1a\u201d, coment\u00f3 Su\u00e1rez.<\/p>\n<p>\u201cTenemos que promover la colaboraci\u00f3n p\u00fablico-privada, una colaboraci\u00f3n directa con las empresas industriales, y la importancia de la financiaci\u00f3n, para apoyar a nuestros cient\u00edficos y que sus investigaciones acaben siendo un producto \u00fatil\u201d, coment\u00f3 <strong>Crist\u00f3bal Belda, director del ISCIII<\/strong>.<\/p>\n<p>Por su parte, <strong>\u00c0ngel Font, director ejecutivo de CAIXARESEARCH INSTITUTE y presidente de PHILEA<\/strong>, a\u00f1adi\u00f3 que la mayor fortaleza de nuestro pa\u00eds es \u201cel talento cient\u00edfico. El ecosistema sanitario ya lo tenemos, pero tenemos que aprovechar la oportunidad que nos brindan los profesionales sanitarios, sobradamente preparados\u201d.<\/p>\n<p>Los asociados estrat\u00e9gicos que hacen posible el Foro Spain Investors Day son BNP PARIBAS, l\u00edder europeo en servicios financieros, y BNP PARIBAS EXANE, uno de los principales intermediarios en renta variable europea. El Foro cuenta con el patrocinio de DELOITTE, ENDESA, CECABANK, AON, IAG, BME y PRISA. Tambi\u00e9n apoyan el encuentro LINKLATERS y EQUIPO ECON\u00d3MICO y las entidades p\u00fablicas ICEX-Invest in Spain, ICO y COFIDES e Invest in Madrid. Spain Investors Day es una empresa de ESTUDIO DE COMUNICACI\u00d3N.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rick R. Su\u00e1rez, presidente de Astrazeneca Espa\u00f1a, avanz\u00f3 que \u201centre 2024 y 2027 una inversi\u00f3n de 800 millones con el hub de innovaci\u00f3n Barcelona\u201d Madrid 10\/01\/2024-. En los \u00faltimos a\u00f1os, Espa\u00f1a ha experimentado un espectacular avance en materia de salud, y la biotecnolog\u00eda tiene un peso cada vez mayor en la econom\u00eda del pa\u00eds. Por&hellip; <a class=\"more-link\" href=\"https:\/\/www.spaininvestorsday.com\/en\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/\">Continue reading <span class=\"screen-reader-text\">LA COLABORACION P\u00daBLICO-PRIVADA, CLAVE PARA EL DESARROLLO DEL SECTOR SALUD<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":21129,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[7,318],"tags":[],"class_list":["post-21128","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notas-de-prensa","category-portada","entry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.6 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>LA COLABORACION P\u00daBLICO-PRIVADA, CLAVE PARA EL DESARROLLO DEL SECTOR SALUD - Spain Investors Day<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LA COLABORACION P\u00daBLICO-PRIVADA, CLAVE PARA EL DESARROLLO DEL SECTOR SALUD - Spain Investors Day\" \/>\n<meta property=\"og:description\" content=\"Rick R. Su\u00e1rez, presidente de Astrazeneca Espa\u00f1a, avanz\u00f3 que \u201centre 2024 y 2027 una inversi\u00f3n de 800 millones con el hub de innovaci\u00f3n Barcelona\u201d Madrid 10\/01\/2024-. En los \u00faltimos a\u00f1os, Espa\u00f1a ha experimentado un espectacular avance en materia de salud, y la biotecnolog\u00eda tiene un peso cada vez mayor en la econom\u00eda del pa\u00eds. Por&hellip; Continue reading LA COLABORACION P\u00daBLICO-PRIVADA, CLAVE PARA EL DESARROLLO DEL SECTOR SALUD\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/\" \/>\n<meta property=\"og:site_name\" content=\"Spain Investors Day\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-10T18:51:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.spaininvestorsday.com\/wp-content\/uploads\/2024\/01\/NOTA-DE-PRENSA-6-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"mmartin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"mmartin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/\"},\"author\":{\"name\":\"mmartin\",\"@id\":\"https:\/\/www.spaininvestorsday.com\/#\/schema\/person\/5a97fa83708e448b6ed2a99027d2c7a6\"},\"headline\":\"LA COLABORACION P\u00daBLICO-PRIVADA, CLAVE PARA EL DESARROLLO DEL SECTOR SALUD\",\"datePublished\":\"2024-01-10T18:51:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/\"},\"wordCount\":524,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.spaininvestorsday.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.spaininvestorsday.com\/wp-content\/uploads\/2024\/01\/NOTA-DE-PRENSA-6-scaled.jpg\",\"articleSection\":[\"Notas de Prensa\",\"Portada\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/\",\"url\":\"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/\",\"name\":\"LA COLABORACION P\u00daBLICO-PRIVADA, CLAVE PARA EL DESARROLLO DEL SECTOR SALUD - Spain Investors Day\",\"isPartOf\":{\"@id\":\"https:\/\/www.spaininvestorsday.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.spaininvestorsday.com\/wp-content\/uploads\/2024\/01\/NOTA-DE-PRENSA-6-scaled.jpg\",\"datePublished\":\"2024-01-10T18:51:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/#primaryimage\",\"url\":\"https:\/\/www.spaininvestorsday.com\/wp-content\/uploads\/2024\/01\/NOTA-DE-PRENSA-6-scaled.jpg\",\"contentUrl\":\"https:\/\/www.spaininvestorsday.com\/wp-content\/uploads\/2024\/01\/NOTA-DE-PRENSA-6-scaled.jpg\",\"width\":2560,\"height\":1707},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/www.spaininvestorsday.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LA COLABORACION P\u00daBLICO-PRIVADA, CLAVE PARA EL DESARROLLO DEL SECTOR SALUD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.spaininvestorsday.com\/#website\",\"url\":\"https:\/\/www.spaininvestorsday.com\/\",\"name\":\"Spain Investors Day\",\"description\":\"El foro profesional \u00fanico en Espa\u00f1a\",\"publisher\":{\"@id\":\"https:\/\/www.spaininvestorsday.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.spaininvestorsday.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.spaininvestorsday.com\/#organization\",\"name\":\"Spain Investors Day\",\"url\":\"https:\/\/www.spaininvestorsday.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.spaininvestorsday.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.spaininvestorsday.com\/wp-content\/uploads\/2021\/10\/SID-2021.svg\",\"contentUrl\":\"https:\/\/www.spaininvestorsday.com\/wp-content\/uploads\/2021\/10\/SID-2021.svg\",\"width\":199,\"height\":79,\"caption\":\"Spain Investors Day\"},\"image\":{\"@id\":\"https:\/\/www.spaininvestorsday.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.spaininvestorsday.com\/#\/schema\/person\/5a97fa83708e448b6ed2a99027d2c7a6\",\"name\":\"mmartin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.spaininvestorsday.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2cdbc25794109186737f2b868bb8d6ff2bb08f76288d542344cbff2280751ac1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2cdbc25794109186737f2b868bb8d6ff2bb08f76288d542344cbff2280751ac1?s=96&d=mm&r=g\",\"caption\":\"mmartin\"},\"url\":\"https:\/\/www.spaininvestorsday.com\/en\/author\/mmartin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LA COLABORACION P\u00daBLICO-PRIVADA, CLAVE PARA EL DESARROLLO DEL SECTOR SALUD - Spain Investors Day","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/","og_locale":"en_US","og_type":"article","og_title":"LA COLABORACION P\u00daBLICO-PRIVADA, CLAVE PARA EL DESARROLLO DEL SECTOR SALUD - Spain Investors Day","og_description":"Rick R. Su\u00e1rez, presidente de Astrazeneca Espa\u00f1a, avanz\u00f3 que \u201centre 2024 y 2027 una inversi\u00f3n de 800 millones con el hub de innovaci\u00f3n Barcelona\u201d Madrid 10\/01\/2024-. En los \u00faltimos a\u00f1os, Espa\u00f1a ha experimentado un espectacular avance en materia de salud, y la biotecnolog\u00eda tiene un peso cada vez mayor en la econom\u00eda del pa\u00eds. Por&hellip; Continue reading LA COLABORACION P\u00daBLICO-PRIVADA, CLAVE PARA EL DESARROLLO DEL SECTOR SALUD","og_url":"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/","og_site_name":"Spain Investors Day","article_published_time":"2024-01-10T18:51:00+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/www.spaininvestorsday.com\/wp-content\/uploads\/2024\/01\/NOTA-DE-PRENSA-6-scaled.jpg","type":"image\/jpeg"}],"author":"mmartin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"mmartin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/#article","isPartOf":{"@id":"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/"},"author":{"name":"mmartin","@id":"https:\/\/www.spaininvestorsday.com\/#\/schema\/person\/5a97fa83708e448b6ed2a99027d2c7a6"},"headline":"LA COLABORACION P\u00daBLICO-PRIVADA, CLAVE PARA EL DESARROLLO DEL SECTOR SALUD","datePublished":"2024-01-10T18:51:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/"},"wordCount":524,"commentCount":0,"publisher":{"@id":"https:\/\/www.spaininvestorsday.com\/#organization"},"image":{"@id":"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/#primaryimage"},"thumbnailUrl":"https:\/\/www.spaininvestorsday.com\/wp-content\/uploads\/2024\/01\/NOTA-DE-PRENSA-6-scaled.jpg","articleSection":["Notas de Prensa","Portada"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/","url":"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/","name":"LA COLABORACION P\u00daBLICO-PRIVADA, CLAVE PARA EL DESARROLLO DEL SECTOR SALUD - Spain Investors Day","isPartOf":{"@id":"https:\/\/www.spaininvestorsday.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/#primaryimage"},"image":{"@id":"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/#primaryimage"},"thumbnailUrl":"https:\/\/www.spaininvestorsday.com\/wp-content\/uploads\/2024\/01\/NOTA-DE-PRENSA-6-scaled.jpg","datePublished":"2024-01-10T18:51:00+00:00","breadcrumb":{"@id":"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/#primaryimage","url":"https:\/\/www.spaininvestorsday.com\/wp-content\/uploads\/2024\/01\/NOTA-DE-PRENSA-6-scaled.jpg","contentUrl":"https:\/\/www.spaininvestorsday.com\/wp-content\/uploads\/2024\/01\/NOTA-DE-PRENSA-6-scaled.jpg","width":2560,"height":1707},{"@type":"BreadcrumbList","@id":"https:\/\/www.spaininvestorsday.com\/la-colaboracion-publico-privada-clave-para-el-desarrollo-del-sector-salud\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.spaininvestorsday.com\/"},{"@type":"ListItem","position":2,"name":"LA COLABORACION P\u00daBLICO-PRIVADA, CLAVE PARA EL DESARROLLO DEL SECTOR SALUD"}]},{"@type":"WebSite","@id":"https:\/\/www.spaininvestorsday.com\/#website","url":"https:\/\/www.spaininvestorsday.com\/","name":"Spain Investors Day","description":"El foro profesional \u00fanico en Espa\u00f1a","publisher":{"@id":"https:\/\/www.spaininvestorsday.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.spaininvestorsday.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.spaininvestorsday.com\/#organization","name":"Spain Investors Day","url":"https:\/\/www.spaininvestorsday.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.spaininvestorsday.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.spaininvestorsday.com\/wp-content\/uploads\/2021\/10\/SID-2021.svg","contentUrl":"https:\/\/www.spaininvestorsday.com\/wp-content\/uploads\/2021\/10\/SID-2021.svg","width":199,"height":79,"caption":"Spain Investors Day"},"image":{"@id":"https:\/\/www.spaininvestorsday.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.spaininvestorsday.com\/#\/schema\/person\/5a97fa83708e448b6ed2a99027d2c7a6","name":"mmartin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.spaininvestorsday.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/2cdbc25794109186737f2b868bb8d6ff2bb08f76288d542344cbff2280751ac1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2cdbc25794109186737f2b868bb8d6ff2bb08f76288d542344cbff2280751ac1?s=96&d=mm&r=g","caption":"mmartin"},"url":"https:\/\/www.spaininvestorsday.com\/en\/author\/mmartin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.spaininvestorsday.com\/en\/wp-json\/wp\/v2\/posts\/21128","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.spaininvestorsday.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.spaininvestorsday.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.spaininvestorsday.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.spaininvestorsday.com\/en\/wp-json\/wp\/v2\/comments?post=21128"}],"version-history":[{"count":1,"href":"https:\/\/www.spaininvestorsday.com\/en\/wp-json\/wp\/v2\/posts\/21128\/revisions"}],"predecessor-version":[{"id":21131,"href":"https:\/\/www.spaininvestorsday.com\/en\/wp-json\/wp\/v2\/posts\/21128\/revisions\/21131"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.spaininvestorsday.com\/en\/wp-json\/wp\/v2\/media\/21129"}],"wp:attachment":[{"href":"https:\/\/www.spaininvestorsday.com\/en\/wp-json\/wp\/v2\/media?parent=21128"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.spaininvestorsday.com\/en\/wp-json\/wp\/v2\/categories?post=21128"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.spaininvestorsday.com\/en\/wp-json\/wp\/v2\/tags?post=21128"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}